Business Wire

UPFIELD

9.1.2024 08:58:37 CET | Business Wire | Press release

Share
Upfield Launches World's First Plastic-free, Recyclable Tub for Its Plant Butters and Spreads

Upfield, global leader in plant-based foods, today announces the world's first plastic-free, recyclable tub for its plant butters and spreads.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240108563070/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Upfield launches world's first plastic-free, recyclable tub for its plant butters and spreads (Photo: Business Wire)

Following four years of innovation, in collaboration with Footprint, MCC and Pagès Group, this introduction marks the beginning of Upfield's transition to a paper solution across its portfolio, delivering on the company's ambition to reduce plastic content by 80% by 2030.

Initially launched in Austria with Flora Plant towards the end of 2023, Upfield expects further scaling of its paper solution, aiming to replace up to two billion plastic tubs by 2030, avoiding more than 25,000 tons of plastic waste per year.

The pioneering paper tubs were developed with Upfield’s leading Research & Development team utilising Footprint's material sciences technology. They are made from compressed wet paper fibres and are waterproof, oil-proof, and recyclable in local paper waste streams. The tub has received Conventional Plastic Free Certification and uses paper from a PEFC-certified supplier. Upfield expects the packaging to achieve home compostability certification by 2025.

David Haines, Group CEO for Upfield, commented, "As a global leader in plant-based foods, we take our responsibility to make a positive impact on the world seriously. Globally, 40% of all plastic produced is for packaging that is used once and then discarded, it is clear that the issue of plastic waste is one of the most critical facing our environment. When we established Upfield, innovating our way out of plastic tubs was our moon-shot and I am very proud of all Upfielders that continue to work towards this goal. Consumers today demand products that benefit both people and the planet. Our plant butters and spreads do exactly that. We're excited about the potential to launch this across our most iconic brands in some of our most important markets."

Unlike many paper packaging solutions, Upfield's paper tubs do not have a plastic liner so they can be recycled along with other paper and cardboard household waste, as verified by a leading European recycling company.

Karina Cerdeira, Head of Packaging for Upfield, said, "We are proud to have created, with Footprint, an innovative paper-based tub that is durable, oil-resistant and appealing and which many thought would be impossible with paper. But after years of dedicated focus from joint Upfield and Footprint R&D teams and dozens of prototypes, we made the impossible, possible. This new paper tub marks a true milestone for sustainable packaging that significantly minimises reliance on plastic. We will continue pushing boundaries through further innovation to adapt for compostability, develop new sizes and formats, and refine towards the optimal solution. We hope what we've achieved inspires other businesses to keep pursuing positive change."

Yoke Chung, Co-founder and Chief Technology & Innovation Officer for Footprint, added, "Footprint's commitment to a more sustainable planet is showcased through our partnership with Upfield. The introduction of a ground-breaking solution, in collaboration with Upfield establishes a pioneering industry standard. This marks the introduction of the first oil-resistant paper tub for plant-based spreads. We are proud to collaborate with Upfield on this transformative endeavour, as it resonates with our shared objective of assisting customers in realizing their sustainability goals. This collaborative effort underscores the transformative influence of innovation in fostering positive environmental change to shape a brighter future for everyone."

To stay up to date on the journey, follow @UpfieldGlobal on social or visit Upfield.com.

About Upfield

Upfield is a global leader in plant-based food, operating in four categories – butters and spreads, creams, liquids and cheeses. Over the last four years, Upfield has been on a journey to separate, stabilise, transform, and turn around our platform which today is unique in the plant-based space – combining scale of historical reach and scale of future growth ambition. We are built on the foundation of our power brands, which achieve high Brand Power Index versus wider consumer goods brands in all our key markets. Our brands are built upon our heritage of 150 years of knowledge of plant-based foods, deep R&D expertise, with 15 manufacturing sites across five continents and an end-to-end supply chain ensuring best service and delivery for our customers and consumers. Upfield's processes, products and people combine to create a business where our portfolio and purpose are completely aligned. www.upfield.com

About Footprint

Footprint is a global materials science and technology company with a clear vision to create a healthier planet and healthier people. Our mission is to provide solutions to eliminate single-use plastics in our food chain. Footprint's engineers use plant-based fiber technology to design, develop, and manufacture bio-based products. Footprint is rapidly expanding into new categories with customized and patented solutions for customers. While working with leading global consumer brands, Footprint's products have already led to a worldwide reduction of millions of pounds of plastic waste from entering the environment.

Footprint was founded in 2014 and employs approximately 2,000 people with operations in the U.S., Mexico, Europe, and Asia. Footprint was named to Fast Company's “Brands that Matter” list in 2022, CNBC’s “Disruptor 50” list in 2021, and Fortune’s “Change the World” list in 2020.

For more information on Footprint’s sustainable solutions, visit www.footprintus.com.

MCC Labels provides the label for the paper tub and Pagès the equipment (robot system) to apply the label.

About MCC Verstraete

MCC Verstraete has over 30 years of experience in offset-printing labels for injection molding, blow molding and thermoforming. In-depth understanding of materials, innovation and sustainability have made MCC Verstraete a world leader, producing over 60 million in mold labels every single day for numerous segments within the packaging industry. The drive for innovation recently led to 2 new product categories: next to polypropylene in mold labels, MCC Verstraete offers Molded Fiber Labeling™ and PP heat-seal die-cut lidding. MCC Verstraete has production sites in Belgium, Australia and the US. Together with MCC Korsini (Turkey) and Karydakis IML SA (Greece), MCC Verstraete forms the IML Business Unit within Multi-Color Corporation.

Visit iml.mcclabel.com/en for more information.

About Pagès Group

Pagès Group is a worldwide company with more than 40 years of expertise in decoration solutions and downstream automation for the packaging industry. The group has subsidiaries in France, in the Netherlands, the USA, Canada and China. As of today, more than 3000 automation systems have been installed in more than 45 countries. Among others, we developed Molded Fiber Labeling (MFL™), a world premiere decoration technology to decorate fiber molded containers for a sustainable and stunning packaging. To learn more about Pagès Group automation solutions, please visit www.pagesgroup.net or follow us on LinkedIn.

About EMSUR

EMSUR is the business unit of Grupo Lantero that provides flexible packaging solutions mainly for the food and beverage sector, home and personal care products, with lamination and printing in both rotogravure and flexography.

It currently has production sites in Europe and America, which allows to develop its activity in more than 80 countries across America, Europe, Africa and Asia. Emsur produces almost 600 million square metres of sleeves, lids, banners, labels, die-cuts, pouches and other flexible products per year.

Innovation, developed through the Innotech team and facilities, is one of their key pillars. Visit www.emsur.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240108563070/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye